Qube Research & Technologies Ltd - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 150 filers reported holding KURA ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q1 2024$758,239
-40.7%
35,548
-60.0%
0.00%
-50.0%
Q4 2023$1,278,224
+180.2%
88,889
+106.2%
0.00%0.0%
Q2 2023$456,146
+94.6%
43,114
+128.3%
0.00%
+100.0%
Q4 2022$234,388
-79.7%
18,887
-65.9%
0.00%
-92.3%
Q2 2021$1,153,000
+245.2%
55,307
+368.6%
0.01%
+160.0%
Q1 2021$334,000
+45.2%
11,802
+67.7%
0.01%
+66.7%
Q4 2020$230,000
-21.5%
7,038
-67.0%
0.00%
-66.7%
Q4 2019$293,00021,2970.01%
Other shareholders
KURA ONCOLOGY INC shareholders Q2 2023
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 206,307$3,363,00011.31%
Foresite Capital Management IV, LLC 1,307,982$21,320,00010.39%
EcoR1 Capital, LLC 4,608,529$75,119,0005.55%
Prosight Management, LP 685,000$11,166,0004.79%
ACUTA CAPITAL PARTNERS, LLC 872,500$14,222,0004.11%
BVF INC/IL 2,775,882$45,247,0002.79%
VR Adviser, LLC 575,000$9,373,0002.24%
ALETHEA CAPITAL MANAGEMENT, LLC 216,171$3,524,0002.06%
DAFNA Capital Management LLC 294,260$4,796,0001.38%
Vivo Capital, LLC 1,050,000$17,115,0001.23%
View complete list of KURA ONCOLOGY INC shareholders